Metropolis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has published its audited financial results for Q4 FY25 and the full financial year ended March 31, 2025 in The Free Press Journal and Navshakti, as required by SEBI listing rules. On a consolidated basis, FY25 total income from operations rose to ₹1,34,631.60 lakhs from ₹1,21,682.58 lakhs in FY24, while net profit after tax grew modestly to ₹12,845.56 lakhs (FY24: ₹12,763.24 lakhs). Consolidated Q4 revenue came in at ₹35,228.23 lakhs versus ₹33,353.94 lakhs in Q4 FY24, but net profit after tax dipped to ₹2,923.13 lakhs from ₹3,652.60 lakhs year-on-year. Standalone FY25 results showed revenue of ₹1,23,358.95 lakhs and net profit after tax of ₹12,478.60 lakhs, though the standalone Q4 after-tax figure of ₹385.06 lakhs was sharply lower than Q3 FY25's ₹2,740.39 lakhs. The results were approved by the Board on May 13, 2025 and signed by Chairperson & Whole-time Director Ameera Shah.
The filing is a routine regulatory disclosure of already-announced results, so it carries no new fundamental information for investors. However, the consolidated FY25 numbers confirm steady revenue growth (~10.6% YoY) but only marginal profit growth (~0.6% YoY), with a clear Q4 YoY profit decline that may draw analyst attention on margins.